MGP Ingredients, Inc.
MGPIMGP Ingredients, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved −41.2% in a year while annual EPS moved −419.9% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is between stages. Underneath, the last four quarters read deteriorating, and 108% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
MGP Ingredients, Inc. trades at $18.7, between stages. That is −11.7% against its own 200-day average. It sits at 17% of a 52-week range of $16 to $30. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (23 weeks and counting).
Today the stock is between stages. At $18.7 it trades −11.7% versus its 200-day average and sits at 17% of its 52-week range ($16–$30).
Against the market, two honest reads. Cumulative: over the last 1.0 years the stock moved −40% while the S&P 500 moved +19% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (23 weeks and counting; last ahead the week of 2026-02-20) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: how the P/E reads against its own history.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
MGP Ingredients, Inc. trades at 53.8× P/E, against too little history to rank. Its long-run median P/E is 62.1×, measured across 0.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 53.8× is against too little history to rank, against a long-run median of 62.1× measured over 0.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −419.9% against a −41.2% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
MGP Ingredients, Inc. reads as deteriorating on its fundamental arc. Deteriorating — revenue and EPS growth are shrinking (revenue growth −18.5% latest against +8.1% at its 12-quarter best), ROCE slipping at 0.8%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −22.9% | −11.5% | — | — |
| Stock price | −41.2% | — | — | — |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
29.0/100 — rank 2 of 5 in Beverages - Wineries & Distilleries · 59% evidence confidence
MGP Ingredients, Inc. scores 29.0 out of 100 against the 5 companies it is compared with in Beverages - Wineries & Distilleries, ranking 2. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 8 + 8.7 + 9.3 + 3 = 29. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
MGP Ingredients, Inc. reported $0.1 B of revenue in the Mar 26 quarter, −8.3% year on year. Over 4 years it has compounded at −3.8% a year. The last full year, FY25, came in at $0.5 B. The last four reported quarters add to $0.5 B.
MGP Ingredients, Inc. reported $0.1 B of revenue in the Mar 26 quarter, −8.3% year on year. Over 4 years it has compounded at −3.8% a year. The last full year, FY25, came in at $0.5 B. The last four reported quarters add to $0.5 B.
FY25 revenue came in at $0.5 B (−22.9% on the year), capping 4 years at −3.8% compound. The latest quarter (Mar 26) printed $0.1 B, −8.3% year on year.
Pace check: the last four quarters averaged −17.6% growth against the decade's −3.8% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −18.5% over the last 4 quarters against −18.6%/yr over the last 8 — stabilising.
→ Revenue slipped — did margins hold as it scaled? Next: −154.5% this quarter (−154.5 pp YoY).
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
MGP Ingredients, Inc.'s operating margin is −154.5% in the Mar 26 quarter, −154.5 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −16.7% to 20.6%. The current quarter is running below every full year in that window.
MGP Ingredients, Inc.'s operating margin is −154.5% in the Mar 26 quarter, −154.5 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −16.7% to 20.6%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is −154.5%, −154.5 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −16.7%–20.6%.
🚨 Why the margin moved: operating margin went −154.5 pp year on year while gross margin went −6.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
→ Margins slipped — did that reach the bottom line? Next: profit null in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
MGP Ingredients, Inc. posted a net loss of $0.1 B in the Mar 26 quarter. That quarter carries a one-off item larger than its own revenue, so the year-on-year figure is an artefact rather than a trading result. The full FY25 year was a loss of $0.1 B. That loss is 118.2% of the quarter's revenue.
MGP Ingredients, Inc. posted a net loss of $0.1 B in the Mar 26 quarter. That quarter carries a one-off item larger than its own revenue, so the year-on-year figure is an artefact rather than a trading result. The full FY25 year was a loss of $0.1 B. That loss is 118.2% of the quarter's revenue.
Mar 26 profit was $−0.1 B, null year on year. On the full year, FY25 printed $−0.1 B (−466.7%).
🚨 Read this profit with care: at $−0.1 B it is larger than the whole quarter's revenue of $0.1 B — no operating business earns more than it sells, so this is a one-off item (a debt-to-equity conversion, a tax write-back or an asset sale), not money the business earned. The underlying operations are running at −154.5% operating margin; the year-on-year jump and any P/E built on this number are artefacts of the one-off, not a real earnings turn.
→ Profit rose — but did the cash follow? Next: 108% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 108% of MGP Ingredients, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.1 B of operating cash against $−0.1 B of profit. After $0.1 B of capital spending, $0.1 B was left as free cash.
FY25: operating cash of $0.1 B against reported profit of $−0.1 B, leaving free cash of $0.1 B after $0.1 B of capital spending. Across the last 3 fiscal years the conversion rate is 108% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
→ So follow the cash to where it goes. Next: $0.0 B of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
MGP Ingredients, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROE is −34% and the ROIC − WACC spread is +3.6 pp.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
MGP Ingredients, Inc. earns a ROE of −15% in FY25. Return on invested capital clears the cost of that capital by +3.6 percentage points, so growth here adds value rather than only size. The wiring behind it is −20.4% net margin on 0.44× asset turns.
FY25 ROE is −15%.
Why the return is what it is — the wiring (FY25): −20.4% net margin × 0.44× asset turns × 1.72× balance-sheet leverage ≈ −15.4% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 8.5% − 4.9% = a +3.6 pp spread. The 4.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.44.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
MGP Ingredients, Inc. paid $0.48 per share over the last four reported quarters. The most recent declaration was $0.12 for Mar 26. Against the current price of $18.7 that is a trailing yield of 2.57%, measured on dividends already paid rather than on a forecast.
MGP Ingredients, Inc. paid $0.48 per share over the last four reported quarters. The most recent declaration was $0.12 for Mar 26. Against the current price of $18.7 that is a trailing yield of 2.57%, measured on dividends already paid rather than on a forecast.
MGP Ingredients, Inc. paid $0.48 per share across the last four reported quarters, most recently $0.12 for Mar 26. Against the current price of $18.7 the trailing twelve months work out to 2.57% — trailing dividends measured against today's price, not a forward estimate.
→ A payout is cash leaving the business. Next: what the balance sheet looks like behind it.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
MGP Ingredients, Inc. carries total debt of $0.2 B against shareholder equity of $0.6 B as of Mar 26, a debt-to-equity of 0.36. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $0.2 B against shareholder equity of $0.6 B — a debt-to-equity of 0.36. Read the returns on this page with that leverage in mind.
→ Who owns this, and are they adding or leaving? Next: short interest is 6.5% of the float.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
6.5% of MGP Ingredients, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 4.0 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 6.5% of the float is sold short, and at typical trading volumes it would take about 4.0 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
MGP Ingredients, Inc.: the Z-score reads 2.29. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.29 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.29.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| MGP Ingredients, Inc. this page | 53.8× | $0B | Deteriorating | |||
| Diageo plc | 20.5× | $49B | Deteriorating | |||
| Brown-Forman Corporation | 18.9× | $13B | Deteriorating | |||
| Agencia Comercial Spirits Ltd | 565.2× | $0B | — | — | — | — |
| SNDL Inc. | — | $0B | No read |
Frequently asked questions
What is MGP Ingredients, Inc.'s stock price today?
MGP Ingredients, Inc. trades at $18.7, −41.2% over the past year. The company is valued at $0.0 B. The stock sits at 17% of its 52-week range of $16–$30, −11.7% versus its 200-day average. Against the S&P 500 it has been behind on a trailing-13-week view for 23 weeks. — as of 29 July 2026.
What were MGP Ingredients, Inc.'s latest quarterly results?
MGP Ingredients, Inc. reported revenue of $0.1 B and a net loss of $0.1 B for the Mar 26 quarter. Earnings per share were $−6.30. The operating margin was −154.5%, 154.5 pp lower than a year earlier. — as of 29 July 2026.
What is MGP Ingredients, Inc.'s revenue?
MGP Ingredients, Inc. reported revenue of $0.1 B in the Mar 26 quarter, −8.3% year on year. For the full FY25 fiscal year, revenue was $0.5 B (−22.9%). Over the last 4 years revenue compounded at −3.8% a year. — as of 29 July 2026.
What is MGP Ingredients, Inc.'s profit?
MGP Ingredients, Inc. earned $−0.1 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $−0.1 B. The operating margin ran −154.5% in the latest quarter. — as of 29 July 2026.
What is MGP Ingredients, Inc.'s market cap?
MGP Ingredients, Inc.'s market capitalisation is $0.0 B at a stock price of $18.7. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.
Does MGP Ingredients, Inc. pay a dividend?
Yes — MGP Ingredients, Inc. declared $0.12 per share for Mar 26, and $0.48 per share across the last four reported quarters. — as of 29 July 2026.
What is MGP Ingredients, Inc.'s dividend per share?
MGP Ingredients, Inc.'s most recently declared dividend is $0.12 per share for Mar 26, giving $0.48 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 29 July 2026.
What is MGP Ingredients, Inc.'s dividend yield?
MGP Ingredients, Inc.'s trailing dividend yield is 2.57%: $0.48 declared per share across the last four reported quarters, against a share price of $18.7. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 29 July 2026.
How is MGP Ingredients, Inc. performing?
MGP Ingredients, Inc.'s latest readings are below. Against the S&P 500 it has been behind on a trailing-13-week view for 23 weeks. This describes what the data did, not a rating. — as of 29 July 2026.
What stage is MGP Ingredients, Inc. in?
Deteriorating — revenue and EPS growth are shrinking (revenue growth −18.5% latest against +8.1% at its 12-quarter best), ROCE slipping at 0.8%. The read comes from the last 12 quarters of growth (revenue growth −18.5% latest, profit growth −2,400.0% latest, eps growth −2,575.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 29 July 2026.
Is MGP Ingredients, Inc. beating the market?
Not lately — on a trailing-13-week view MGP Ingredients, Inc. is currently behind the S&P 500 (23 weeks and counting; last ahead the week of 2026-02-20), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.0 years the stock moved −40% against the S&P 500's +19% — behind the index over the full window. — as of 29 July 2026.
Will MGP Ingredients, Inc.'s stock price go up?
This page publishes no price forecast for MGP Ingredients, Inc. What it measures instead: the stock price is $18.7. Direction is not something this site claims to know. — as of 29 July 2026.
Is the market betting against MGP Ingredients, Inc.?
Somewhat — short interest is 6.5% of MGP Ingredients, Inc.'s tradable float, about 4.0 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 29 July 2026.
Does MGP Ingredients, Inc. have too much debt?
It is moderate — MGP Ingredients, Inc.'s debt-to-equity is 0.44. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 29 July 2026.
What is MGP Ingredients, Inc.'s capex?
MGP Ingredients, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.1 B. — as of 29 July 2026.
What is MGP Ingredients, Inc.'s cash flow?
MGP Ingredients, Inc. generated $0.1 B of operating cash flow in FY25 and $0.1 B of free cash flow after $0.1 B of capital spending. Reported profit that year was $−0.1 B, so operating cash ran ahead of profit. — as of 29 July 2026.
Is MGP Ingredients, Inc.'s profit real cash?
Yes — over the last 3 fiscal years, 108% of MGP Ingredients, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $0.1 B against reported profit of $−0.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 29 July 2026.
How financially safe is MGP Ingredients, Inc.?
On the balance sheet, the Z-score reads 2.29 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 29 July 2026.
Where is MGP Ingredients, Inc. in its business cycle?
MGP Ingredients, Inc.'s FY25 operating margin was −16.7%, against a 5-year band of −16.7%–20.6%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran −154.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.
What could break the MGP Ingredients, Inc. story?
The sharpest disagreement: the price moved −41.2% in a year while annual EPS moved −419.9% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.
Is MGP Ingredients, Inc. a stock worth studying right now?
This is not investment advice. The machine read: MGP Ingredients, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.